Fingerprint
Dive into the research topics of 'A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia
John Mascarenhas*, Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub, Claire N. Harrison, Mary Frances McMullin, Alessandro M. Vannucchi, Joanne Ewing, Casey L. O'Connell, Jean Jacques Kiladjian, Adam J. Mead, Elliott F. Winton, David S. Leibowitz, Valerio De Stefano, Murat O. Arcasoy, Craig M. Kessler, Rosalind Catchatourian, Damiano Rondelli
*Corresponding author for this work
- Icahn School of Medicine at Mount Sinai
- Mayo Clinic Scottsdale, AZ
- University of Utah
- Papa Giovanni XXIII Hospital
- Wake Forest University
- University of Kansas Cancer Center
- Guy's and St Thomas' NHS Foundation Trust
- Queen's University Belfast
- Azienda Ospedaliera Careggi
- University Hospitals Birmingham NHS Foundation Trust
- University of Southern California
- Université Paris Cité
- Oxford University Hospitals NHS Foundation Trust
- Emory University
- Palo Alto Medical Foundation
- Catholic University of Sacred Heart
- Duke University
- Georgetown University
- Stroger Hospital of Cook County
- University of Illinois at Chicago
- New York Presbyterian Hospital
- Sheba Medical Center at Tel Hashomer
- Memorial Sloan-Kettering Cancer Center
- Mayo Clinic Rochester, MN
- New York Blood Center
- Department of Population Health
- New York University
- IQVIA Inc.
- IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
- University of Texas Health Science Center at San Antonio
Research output: Contribution to journal › Article › peer-review
88
Scopus
citations